Tolterodine for overactive bladder: Time to onset of action, preferred dosage, and 9-month follow-up

A. Atan, B. R. Konety, J. R. Erickson, T. Yokoyama, D. Y. Kim, M. B. Chancellor

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint Dive into the research topics of 'Tolterodine for overactive bladder: Time to onset of action, preferred dosage, and 9-month follow-up'. Together they form a unique fingerprint.

Medicine & Life Sciences